Tecfidera 240 mg Norge - norsk - Statens legemiddelverk

tecfidera 240 mg

2care4 aps - dimetylfumarat - enterokapsel, hard - 240 mg

Tecfidera 240 mg Norge - norsk - Statens legemiddelverk

tecfidera 240 mg

orifarm as - dimetylfumarat - enterokapsel, hard - 240 mg

Tecfidera 120 mg Norge - norsk - Statens legemiddelverk

tecfidera 120 mg

orifarm as - dimetylfumarat - enterokapsel, hard - 120 mg

Vumerity Den europeiske union - norsk - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - multippel sklerose, relapsing-remitting - immunsuppressive - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Teriflunomide Mylan Den europeiske union - norsk - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multippel sklerose, relapsing-remitting - immunsuppressive - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Den europeiske union - norsk - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - multippel sklerose, relapsing-remitting - immunosuppressants, selektiv immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Spiriva Respimat 2.5 mikrog Norge - norsk - Statens legemiddelverk

spiriva respimat 2.5 mikrog

boehringer ingelheim international gmbh - tiotropiumbromid - inhalasjonsvæske, oppløsning - 2.5 mikrog

Vocabria Den europeiske union - norsk - EMA (European Medicines Agency)

vocabria

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv-infeksjoner - antivirale midler til systemisk bruk - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Apretude Den europeiske union - norsk - EMA (European Medicines Agency)

apretude

viiv healthcare b.v. - cabotegravir - hiv-infeksjoner - antivirale midler til systemisk bruk - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 og 5.

Fampyra Den europeiske union - norsk - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - multippel sklerose - andre nervesystemet narkotika - fampyra angis for forbedring av gåing i voksen pasienter med multippel sklerose innen funksjonshemming (utvidet funksjonshemming status skala 4-7).